Paliperidona Krka (Paliperidone)

Paliperidone, the active ingredient in Paliperidona Krka, is a atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adults.

GNH USA supplies Paliperidona Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone is used in psychiatric care to manage psychotic disorders and related symptoms. - Schizophrenia: Reduces hallucinations, delusions and thought disorder. - Schizoaffective disorder: Controls both mood and psychotic symptoms. - Maintenance therapy: Helps prevent relapse after an acute episode.

Paliperidone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Akathisia: Restlessness and an urge to move. - Drowsiness: Feeling unusually sleepy. - Weight gain: Increased appetite leading to weight increase. - Dry mouth: Reduced salivation. - Constipation: Decreased bowel motility. - Elevated prolactin: Hormonal changes causing menstrual disturbances.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: Potentially life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: Involuntary, repetitive movements. - Seizures: Increased risk of convulsive episodes. - Orthostatic hypotension: Marked drop in blood pressure on standing. - Cardiac arrhythmias: QT‑interval prolongation. - Severe hyperglycaemia: Marked increase in blood glucose levels.

Before initiating Paliperidona Krka, clinicians should evaluate patient history and monitor for specific safety concerns. - Cardiovascular assessment: Check for history of arrhythmias or QT prolongation. - Metabolic monitoring: Track weight, glucose and lipid profiles regularly. - Prolactin levels: Observe for signs of hyperprolactinemia. - CNS disorders: Use cautiously in patients with seizures or Parkinsonian features. - Elderly patients: Start at lower doses and monitor for falls and sedation. - Store below 25°C: Keep in the original packaging, protect from moisture and direct sunlight.

Paliperidone can interact with several medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): Increase paliperidone exposure. - Strong CYP3A4 inducers: Reduce the ​...